Sats: GF-BPCTB10-B241 De viktigaste analysresultaten r fljande: BPC-157-halt: 16,04 mg Identifiering av BPC-157 med RT: 0,993 Renhet fr BPC-157: ver 99,8 procent Molekylr jonmassa fr BPC-157: 1418 Da Innehll i TB-500-analysen: 13,44 mg Identifiering av TB-500 med RT: 0,999 TB-500 Renhet: 99,6 procent TB-500 Molekyljonens massvrde: 4962 Da Bakteriella endotoxiner: under 0,001 EU per mg Totalt antal aeroba mikroorganismer: ej pvisat Totalt antal jst- och mgelceller: ej pvisat Produktversikt BPC-157/TB-500 r en forskningsformulering med tv peptider som kombinerar tv ingende studerade peptidfreningar i ett enda laboratoriepreparat
The most commonly reported side effects include: Nausea Diarrhoea Vomiting Mild stomach discomfort Constipation In TRIUMPH-1, treatment discontinuation due to adverse events rose with dose: approximately 4.1% at 4 mg, 6.9% at 9 mg, and 11.3% at 12 mg , compared with 4.9% in the placebo group
The Biggest Risk: Taking Another Gummy Too Soon Important point: The main problem is not always the first gummy
All tests were measured on an Olympus AU2700 analyzer, with original test reagents (Olympus Diagnostica, Lismeehan, Ireland)
These symptoms typically subside as the body adjusts to the medication
2007 Sep 1;43(5):853-9
